New linker structures applied in glycosite-specific antibody drug conjugates
文献类型:期刊论文
作者 | Faridoon2; Shi, Wei1,2; Qin, Ken1,2; Tang, Yubo2,3; Li, Mingjie2,3; Guan, Dongliang1,2; Tian, Xiaobo2; Jiang, Bofeng2; Dong, Jinhua3; Tang, Feng1,2 |
刊名 | ORGANIC CHEMISTRY FRONTIERS
![]() |
出版日期 | 2019-09-07 |
卷号 | 6期号:17页码:3144-3149 |
ISSN号 | 2052-4129 |
DOI | 10.1039/c9qo00646j |
通讯作者 | Tang, Feng(tangfeng2013@simm.ac.cn) ; Huang, Wei(huangwei@simm.ac.cn) |
英文摘要 | Glycosite-specific antibody drug conjugates (ADCs) allow selective conjugation of a small-molecule payload onto the conserved N-glycan of Asn297 of antibody Fc domains, and lead to a highly homogeneous structure in specific conjugation site and fixed drug-to-antibody ratio (DAR), which are crucial for pharmacokinetics, pharmacodynamics and efficacy of the ADCs. The limited structural diversity of linkers in glycosite-specific ADCs is due to the scarcity of efficient chemistry for IgG glycan conjugation. Herein we describe two new linkers, 2-aminobenzamidoxime and mercaptoethylpyrazolone, which rapidly, efficiently and selectively react with aldehyde-tagged N-glycan after IgG glycoengineering. The constructed novel glycosite-specific ADCs demonstrated excellent anti-tumor cytotoxicity and fluorescence properties or enhanced stability. |
WOS关键词 | SITE-SPECIFIC CONJUGATION ; IGG ANTIBODIES ; GLYCOSYLATION ; PROTEINS |
资助项目 | National Natural Science Foundation of China (NNSFC)[21572244] ; National Natural Science Foundation of China (NNSFC)[21877116] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China[2018ZX09711002-006] ; China Postdoctoral Science Foundation Postdoctoral Innovative Talent Support Program[BX20180339] |
WOS研究方向 | Chemistry |
语种 | 英语 |
WOS记录号 | WOS:000483840200012 |
出版者 | ROYAL SOC CHEMISTRY |
源URL | [http://119.78.100.183/handle/2S10ELR8/288796] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Tang, Feng; Huang, Wei |
作者单位 | 1.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 2.Chinese Acad Sci, CAS Key Lab Receptor Res, CAS Ctr Excellence Mol Cell Sci, Ctr Biotherapeut Discovery Res,Shanghai Inst Mat, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 3.Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China |
推荐引用方式 GB/T 7714 | Faridoon,Shi, Wei,Qin, Ken,et al. New linker structures applied in glycosite-specific antibody drug conjugates[J]. ORGANIC CHEMISTRY FRONTIERS,2019,6(17):3144-3149. |
APA | Faridoon.,Shi, Wei.,Qin, Ken.,Tang, Yubo.,Li, Mingjie.,...&Huang, Wei.(2019).New linker structures applied in glycosite-specific antibody drug conjugates.ORGANIC CHEMISTRY FRONTIERS,6(17),3144-3149. |
MLA | Faridoon,et al."New linker structures applied in glycosite-specific antibody drug conjugates".ORGANIC CHEMISTRY FRONTIERS 6.17(2019):3144-3149. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。